Abstract 2898: Development of the lipid kinase PIKfyve PROTAC degrader against neuroendocrine prostate cancer
Yuanyuan Qiao(University of Michigan), Arul M. Chinnaiyan(University of Michigan), Sarah Nicole Yee(University of Michigan), Yi Bao(Stevens Institute of Technology), Chungen Li(Chinese Academy of Sciences), Zhen Wang(Beth Israel Deaconess Medical Center), Yuping Zhang(University of Michigan), Yang Zheng(Shanghai Ninth People's Hospital), Yuzhuo Wang(BC Cancer Agency), Ke Ding(China Pharmaceutical University), Caleb Cheng(University of Michigan), Xia Jiang(University of Michigan)
Cited by 0
Related Papers
Activating ESR1 mutations in hormone-resistant metastatic breast cancer
|Nature Genetics|2013|1.2k
Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing
|Nature Genetics|2013|818
Identification of Targetable FGFR Gene Fusions in Diverse Cancers
|Cancer Discovery|2013|737
Personalized Oncology Through Integrative High-Throughput Sequencing: A Pilot Study
|Science Translational Medicine|2011|637